Market Capitalization of Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd
NSE: GLPL
Market Cap
Key Highlights
- The Market Cap of Goldline Pharmaceutical Ltd is ₹ 51.78 crore as of 20 May 26 The Latest Trading Price of Goldline Pharmaceutical Ltd is ₹ 53.94 as of 20 May 15:30 .
Goldline Pharmaceutical Ltd
NSE: GLPL
Share Price
Market Price of Goldline Pharmaceutical Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 20 May 2026 | 53.94 |
| 19 May 2026 | 56.77 |
BlinkX Score for Goldline Pharmaceutical Ltd
Asset Value vs Market Value of Goldline Pharmaceutical Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Goldline Pharmaceutical Ltd
Historical P/E Ratio of Goldline Pharmaceutical Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Goldline Pharmaceutical Ltd
Historical Revenue of Goldline Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Goldline Pharmaceutical Ltd
Historical EBITDA of Goldline Pharmaceutical Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Goldline Pharmaceutical Ltd
Historical Net Profit of Goldline Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Goldline Pharmaceutical Ltd
Dividend Payout Over Time
About Goldline Pharmaceutical Ltd
- Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
- Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
- September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
- Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
- The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.
Goldline Pharmaceutical Ltd News Hub
BSE SME Goldline Pharmaceutical delivers a dose of listing gains
The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc
Read more
19 May 26
